BSE: DRREDDY - Dr. Reddy's Laboratories Limited

Yield per half year: -79.92%
Sector: Healthcare

Dr. Reddy's Laboratories Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
18.55 56.11 -66.95% 26.56 -30.18%
P/S 3.7 17.79 -79.21%
P/BV 3.68 8.08 -54.45%
P/FCF 54.29 -381.8 -114.22%
Ev/Ebitda 10.41 4.22 146.85%
Ev/S 3.73 16.49 -77.36%
Ev/FCF 57.9 -240.24 -124.1%
E/P 0.057 0.0159 258.13%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
30.16 -18.77 -260.67% 22.63 +33.29%
ROE 21.69 3.69 488.5%
ROA 15.68 3.44 355.4%
ROIC 21.41 11.26 90.12%
ROS 19.95 -47.96 -141.6%
ROCE 22.94 5.09 350.65%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.222 24.38 -99.09% 0.3919 -43.34%
Nеt Debt/Ebitda 0.1265 21.3 -99.41%
Debt/Ratio 0.0426 0.126 -66.15%
Debt/Equity 0.2492 4.64 -94.62%
Debt/Net Income 0.2967 -49.02 -100.61%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0.33/10
0.126 0.6496 -80.6% 0.2957 -57.39%
Number of years of dividend growth 1 0.92 8.7%
DSI 0.9286 0.8171 13.64%
Average dividend growth -6.89 1.6 -530.91%
Average percentage for 5 years 0.2957 0.8856 -66.61%
Average percentage for payments 18.39 22.22 -17.25%
Difference from average difference in sector -0.5236

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
7/10
59.37 72.87 -18.53%
Growth impulse Ebitda in 5 years 109.49 72.97 50.05%
Growth impulse Net Income in 5 years 174.85 159.06 9.93%
Growth impulse FCF in 5 years -24.14 85.7 -128.17%
Growth impulse EPS in 5 years 184.89 104.61 76.74%
IP Score
6.47/10

Similar companies

Divi`s Laboratories Limited

Poly Medicure Limited

Marksans Pharma Limited

Sun Pharmaceutical Industries Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription